• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$0.01 $0.00 (0.00%)

Quote as of

NUTRA PHARMA CORP

NASDAQOTCBB:NPHC.OB

Nutra Pharma Begins Affiliate Sales & Marketing Program for the Distribution of Nyloxin(TM)

Nutra Pharma Engages Marketing Firm for the Branding and Channel Development of Nyloxin™

Nutra Pharma Letter to Shareholders

Nutra Pharma Announces Publication of a New Mechanism Study of Alpha-Cobratoxin in the Treatment of Pain

Nutra Pharma Announces Publication of a New Mechanism Study of Alpha-Cobratoxin in the Treatment of Pain

Jeffrey Gottfurcht Children’s Arthritis Foundation Grants Dream to Pearl City, Hawaii Teenager with Juvenile Arthritis

First Rheumatoid Arthritis Patient to Summit Mt. Everest Announces Plans to Scale Seven Summits, While Continuing to Bring Awareness to Arthritis

Nutra Pharma CEO Interviewed by Wall Street Reporter

Nutra Pharma CEO Interviewed by Wall Street Reporter

Nutra Pharma Receives Patent For Their Multiple Sclerosis Drug

Nutra Pharma Receives Patent for Their Multiple Sclerosis Drug

Nutra Pharma Receives Patent for Their Multiple Sclerosis Drug

Nutra Pharma Announces Distributor in Panama for Their Nyloxin Pain Relievers

NPHC in Panama now

Nutra Pharma Announces Distributor in Panama for Their Nyloxin Pain Relievers

First Rheumatoid Arthritis Patient Announces Plans to Scale the Seven Summits, Climbing Highest Peak on Every Continent

Nutra Pharma Pain Drug Receives Indian Regulatory Approval

Nutra Pharma Receives Regulatory Approval to Market Nyloxin in India

Nutra Pharma Announces Jordan Distributor For Their Nyloxin Pain Relievers

Nutra Pharma Announces Jordan Distributor for Their Nyloxin Pain Relievers

First Rheumatoid Arthritis Patient Summits Mount Everest

Nutra Pharma Announces Exclusive Distributor for Their Nyloxin Pain Relievers in Lebanon

World's First Mountain Climber With Rheumatoid Arthritis Successfully Scaled Mount Everest With the Pain Relief Help of Nyloxin(TM), a Drug From Nutra Pharma Corporation

Nutra Pharma Announces Exclusive Distributor for Their Nyloxin Pain Relievers in Venezuela

Nutra Pharma Announces Nyloxin(TM) Distribution Through Innovatix

First Rheumatoid Arthritis Patient to Climb Mount Everest

USPTO approves new patent for Nutra Pharma Cobratoxin

Nutra Pharma Announces Publication of a Review Article on Cobra Venom and Its Use as an Analgesic Nutra Pharma Announces the Publication of a Review Article, "Cobra Venom: A Review of the Old Alternative to Opiate Analgesics," Published in the January Is

Nutra Pharma Announces Publication of a Review Article on Cobra Venom and Its Use as an Analgesic

Nutra Pharma Announces Granted Continuing Education for Pharmacists

Nutra Pharma Announces Granted Continuing Education for Pharmacists Nutra Pharma Announces Providing an Educational Grant for the Pharmacist Continuing Education Course "Over-the-Counter Use of Neuroactive Peptides for the Treatment of Chronic Pain"

Nutra Pharma Announces Granted Continuing Education for Pharmacists

Nutra Pharma Sponsors Climber With Rheumatoid Arthritis to Scale World's Highest Mountain

Nutra Pharma receives grant under QTPD program

Nutra Pharma Awarded Grant Under the Qualifying Therapeutic Discovery Project Program

Nutra Pharma chooses Nutritional Alliance to distribute Nyloxin

Nutra Pharma Selects Nutritional Alliance as Its Global Sales Agent

Nutra Pharma Amends Cobroxin Distribution Agreement With XenaCare Holdings

Nutra Pharma Amends Cobroxin Distribution Agreement With XenaCare Holdings

Nutra Pharma Corp. (NPHC) Begins Drug Registration Process In India For Nyloxin - A Treatment For Moderate To Severe Chronic Pain

See More Articles...